Table 2.

Recommendations for administration of 23-valent pneumococcal vaccine and 13-valent pneumococcal conjugate vaccine in children

Age	PPV23	PCV13
>2 yr		4 doses, one dose at 2, 4, 6, 12–15 mo
2–4 yr		1 dose if not vaccinated previously
2–5 yr		1 or 2 doses if not vaccinated previously and has chronic medical condition including sickle cell disease, a damaged spleen or no spleen, cochlear implant, cerebrospinal fluid leaks, HIV or other diseases that affect the immune system (such as diabetes, cancer, and liver disease), chronic heart or lung disease; children who take medications that affect the immune system (such as chemotherapy or corticosteroids)
2 yr and above	One dose if patient has chronic medical condition including chronic heart disease, chronic lung disease, sickle cell disease, diabetes, alcoholism, cirrhosis, leakage of cerebrospinal fluid or cochlear implant, immunocompromised condition, and taking immunosuppressant drugs

Definition of abbreviations: PCV13 = 13-valent pneumococcal conjugate vaccine; PPV23 = 23-valent pneumococcal polysaccharide vaccine.

Note: Adapted from Reference 39.